Noua Zeelandă - engleză - Medsafe (Medicines Safety Authority)

apotex nz ltd - famciclovir 125mg - film coated tablet - 125 mg - active: famciclovir 125mg excipient: hypromellose macrogol 8000 poloxamer purified water stearic acid titanium dioxide - apo-famciclovir is indicated for: · the treatment of acute herpes zoster, including ophthalmic zoster and decreases the duration of associated post-herpetic neuralgia (phn). · the acute treatment of first episode and recurrences of genital herpes infections, and for the suppression of recurrent genital herpes. · the treatment of recurrent herpes labialis (cold sores) in immunocompromised adults aged 18 years and over. · in immunocompromised patients with herpes zoster or herpes simplex infections.

Noua Zeelandă - engleză - Medsafe (Medicines Safety Authority)

apotex nz ltd - famciclovir 250mg - film coated tablet - 250 mg - active: famciclovir 250mg excipient: hypromellose macrogol 8000 poloxamer purified water stearic acid titanium dioxide - apo-famciclovir is indicated for: · the treatment of acute herpes zoster, including ophthalmic zoster and decreases the duration of associated post-herpetic neuralgia (phn). · the acute treatment of first episode and recurrences of genital herpes infections, and for the suppression of recurrent genital herpes. · the treatment of recurrent herpes labialis (cold sores) in immunocompromised adults aged 18 years and over. · in immunocompromised patients with herpes zoster or herpes simplex infections.

Noua Zeelandă - engleză - Medsafe (Medicines Safety Authority)

apotex nz ltd - famciclovir 500mg - film coated tablet - 500 mg - active: famciclovir 500mg excipient: hypromellose macrogol 8000 poloxamer purified water stearic acid titanium dioxide - apo-famciclovir is indicated for: · the treatment of acute herpes zoster, including ophthalmic zoster and decreases the duration of associated post-herpetic neuralgia (phn). · the acute treatment of first episode and recurrences of genital herpes infections, and for the suppression of recurrent genital herpes. · the treatment of recurrent herpes labialis (cold sores) in immunocompromised adults aged 18 years and over. · in immunocompromised patients with herpes zoster or herpes simplex infections.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - famciclovir, quantity: 125 mg - tablet, film coated - excipient ingredients: purified water; magnesium stearate; microcrystalline cellulose; hyprolose; silicon dioxide; sodium starch glycollate; titanium dioxide; lactose monohydrate; hypromellose; macrogol 4000 - famciclovir mylan is indicated for the treatment of herpes zoster infection in adult patients who commence therapy within 72 hours of the onset of rash. greatest benefit occurs if the drug is started within 48 hours.. efficacy has not been demonstrated in patients less than 50 years of age, although the occasional younger patient with severe herpes zoster may benefit from therapy with famciclovir. herpes zoster is generally a milder condition in younger patients.. famciclovir mylan is also indicated for the treatment of recurrent episodes of genital herpes in adults and adolescents 12 years of age and older.. famciclovir mylan is also indicated for suppression of recurrent genital herpes.. famciclovir mylan is also indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adult patients.. famciclovir mylan is also indicated in immunocompromised patients for:. - treatment of uncomplicated herpes zoster. - treatment of recurrent herpes simplex. - suppression of recurrent herpes simplex.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - famciclovir, quantity: 250 mg - tablet, film coated - excipient ingredients: hyprolose; magnesium stearate; sodium starch glycollate; silicon dioxide; microcrystalline cellulose; purified water; titanium dioxide; lactose monohydrate; hypromellose; macrogol 4000 - famciclovir mylan is indicated for the treatment of herpes zoster infection in adult patients who commence therapy within 72 hours of the onset of rash. greatest benefit occurs if the drug is started within 48 hours.. efficacy has not been demonstrated in patients less than 50 years of age, although the occasional younger patient with severe herpes zoster may benefit from therapy with famciclovir. herpes zoster is generally a milder condition in younger patients.. famciclovir mylan is also indicated for the treatment of recurrent episodes of genital herpes in adults and adolescents 12 years of age and older.. famciclovir mylan is also indicated for suppression of recurrent genital herpes.. famciclovir mylan is also indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adult patients.. famciclovir mylan is also indicated in immunocompromised patients for:. - treatment of uncomplicated herpes zoster. - treatment of recurrent herpes simplex. - suppression of recurrent herpes simplex.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - famciclovir, quantity: 500 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; sodium starch glycollate; hyprolose; silicon dioxide; magnesium stearate; purified water; titanium dioxide; lactose monohydrate; hypromellose; macrogol 4000 - famciclovir mylan is indicated for the treatment of herpes zoster infection in adult patients who commence therapy within 72 hours of the onset of rash. greatest benefit occurs if the drug is started within 48 hours.. efficacy has not been demonstrated in patients less than 50 years of age, although the occasional younger patient with severe herpes zoster may benefit from therapy with famciclovir. herpes zoster is generally a milder condition in younger patients.. famciclovir mylan is also indicated for the treatment of recurrent episodes of genital herpes in adults and adolescents 12 years of age and older.. famciclovir mylan is also indicated for suppression of recurrent genital herpes.. famciclovir mylan is also indicated for the treatment of recurrent herpes labialis (cold sores) in immunocompetent adult patients.. famciclovir mylan is also indicated in immunocompromised patients for:. - treatment of uncomplicated herpes zoster. - treatment of recurrent herpes simplex. - suppression of recurrent herpes simplex.

Australia - engleză - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - famciclovir -

Australia - engleză - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - famciclovir -

Australia - engleză - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - famciclovir -

Australia - engleză - Department of Health (Therapeutic Goods Administration)

fair-med healthcare australia pty ltd - famciclovir -